Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
175MO Evaluation of an AI-enabled platform for cancer prevention and genetic risk assessment in unaffected individuals: A randomized study
0
Zitationen
8
Autoren
2025
Jahr
Abstract
Artificial intelligence (AI) is increasingly applied in cancer diagnostics and treatment, yet its role in cancer prevention and hereditary risk assessment remains underexplored. We conducted a prospective randomized study of an AI-enabled platform (OncoDefend) to evaluate feasibility, accuracy, and behavioral impact in unaffected individuals in India.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.549 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.443 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.941 Zit.
BioBERT: a pre-trained biomedical language representation model for biomedical text mining
2019 · 6.792 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.781 Zit.